CURLF News and Press, Curaleaf Holdings Inc From 05/16/24

NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- FinancialBuzz.com News Commentary The breathalyzer market has experienced significant growth due to a heightened awareness of the dangers associated with impaired driving and the stringent enforcement of alcohol consumption laws globally. B...

2024-05-14 13:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Many investors and analysts have been bullish on the prospects of the U.S. cannabis industry since its legalization in several states. However, despite being legal in 40 out of 50 U.S. stat...

2024-05-11 14:00:00 ET More on cannabis reform Marijuana THC potency at all-time high - DEA Cannabis Continues Powering To Big Gains With Historic DEA Rescheduling MSOS: Best Play On U.S. Cannabis Regulations Green Thumb Industries Is No Longer A Se...

2024-05-10 16:25:01 ET The DEA said that the average percentage of THC, the psychoactive cannabinoid in marijuana known for giving users a "high" feeling, has been steadily increasing and reached an all-time high of 16% in 2022.... Read the full article on Seeking Alpha For furt...

2024-05-09 20:38:08 ET Curaleaf Holdings, Inc (CURLF) Q1 2024 Results Conference Call May 09, 2024 05:00 PM ET Company Participants Camilo Lyon - Chief Investment Officer Boris Jordan - Executive Chairman Matt Darin - Chief Executive Officer Ed Kremer - Chief...

2024-05-09 16:05:51 ET More on Curaleaf Investors Have Another Chance To Sell Curaleaf Curaleaf: New York To The Rescue Curaleaf: Wild Divide Between Wall Street And SA Analysts Sentiments White House mum on where Biden stands with marijuana rescheduling ...

Curaleaf Reports First Quarter 2024 Results Canada NewsWire First quarter 2024 revenue of $339 million , representing an increase of 2% year-over-year and adjusted gross margin(1) of 48% First quarter 2024 adjusted EBITDA(1) of $77 million , representing 23% of...

2024-05-09 12:13:02 ET Though President Biden has often voiced his support of marijuana reforms, he has yet to say whether he supports the DEA's reported plan to reschedule cannabis as a Schedule III drug.... Read the full article on Seeking Alpha For further details see: Wh...

2024-05-09 09:24:55 ET Summary The Department of Justice has recommended that cannabis be rescheduled to a Schedule III drug. Rescheduling will nearly double Verano's FCF given the removal of the 280E tax burden. Verano is a leading U.S. cannabis multi-state operator (MSO) and a p...

AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...